New RNA tools for CRISPR/Cas9

Integrated DNA Technologies (IDT) will host an informative webinar, entitled ‘New RNA Tools for Optimized CRISPR/Cas9 Genome Editing’, on Wednesday, October 7, 2015. Ashley Jacobi, a scientist in the Molecular Genetics Applied Research Group at IDT, and an expert in the application of synthetic nucleic acids, will present the webinar at 9 am and 1 pm Central Standard Time. The webinar will explain how IDT has developed and optimized these new tools and show how researchers can benefit from using the 2-part RNA system over other technologies.

The use of the CRISPR/Cas9 system for genetic modification is transforming research across organisms, from bacteria to human cells. The sgRNA (single guide RNA)-based system is now one of the leading tools for genome editing, yet it has a number of drawbacks. Now, following extensive research, IDT has developed new RNA tools that optimize the natural 2-part RNA CRISPR/Cas9 system. Designed for more efficient delivery and cutting, without major alterations to current protocols, the enhanced crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA) tools improve success rates in genome editing. This webinar provides a review of IDT’s research and development of these new tools ahead of their impending product launch. Attendees will learn how these components are generated, and gain an insight into their strengths over existing tools and techniques to make genome editing more effective and cost-efficient in their own research.

To register for the webinar, please select the desired session on the webinar registration page, or via our website at www.idtdna.com.

 

US/Central

Europe/London

Session 1 October 7

9:00 AM

3:00 PM

Session 2 October 7

1:00 PM

7:00 PM

Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the world, serving all areas of life sciences research and development. IDT’s primary business is the production of custom, synthetic nucleic acids for molecular biology applications, including qPCR, sequencing, synthetic biology, and functional genomics. The company manufactures and ships an average of 44,000 custom nucleic acids per day to more than 82,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, California; Leuven, Belgium; and Singapore.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Integrated DNA Technologies. (2019, June 20). New RNA tools for CRISPR/Cas9. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20151001/New-RNA-tools-for-CRISPRCas9.aspx.

  • MLA

    Integrated DNA Technologies. "New RNA tools for CRISPR/Cas9". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20151001/New-RNA-tools-for-CRISPRCas9.aspx>.

  • Chicago

    Integrated DNA Technologies. "New RNA tools for CRISPR/Cas9". News-Medical. https://www.news-medical.net/news/20151001/New-RNA-tools-for-CRISPRCas9.aspx. (accessed November 21, 2024).

  • Harvard

    Integrated DNA Technologies. 2019. New RNA tools for CRISPR/Cas9. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20151001/New-RNA-tools-for-CRISPRCas9.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.